Author's posts
Global Health Research Needs More Than A Makeover
Research shows that global health has not shed its colonial past. This is reflected in who drives the research agenda, who dominates authorship, and who edits the research.
Fighting TB: Slow Progress Should Ignite Action
Today’s WHO Global Tuberculosis Report shows slow progress. Greater urgency and patient-driven advocacy is required to switch gears.
Better Therapies For TB Are Here, But They Will Not Deliver Themselves
Innovative research and partnerships are delivering us, for the first time, substantially shorter and safer drug treatments for tuberculosis. The challenge now is ensure these new drugs reach those who need them the most.
WHO List of Essential Tests Gets An Upgrade
Essential medicines require essential diagnostics. Today, the World Health Organization released the 2nd Edition of the Model List of Essential Diagnostics. The new list covers 122 test categories, and covers a wider range of communicable and non-commu…
Can Pharmacies Improve Global Health Delivery By Taking Tests Closer to People?
Pharmacies are a major source of healthcare in many low- and middle-income countries. They could take tests closer to people, and help address the last mile problem of getting essential diagnostic tests to those who need them the most.
A Resource For Global Health Innovators
Innovations are critical to tackle some of the biggest challenges in global health. The World Health Organization has just launched the Health Product Profile Directory, a free-to-use online, searchable database of target product profiles for various h…
Fighting Fire With Fire: Can We Kill Super-Resistant Mycobacteria With Viruses?
Drug-resistant TB has high fatality and new antibiotics are scarce. A human study shows that bacteriophages might have a role in treating Mycobacterium abscessus, an infection that resembles drug-resistant TB. The door is now open for similar studies …
Drug-Resistant TB: A Clear And Present Danger
Drug-resistant forms of tuberculosis (DR-TB) have emerged as a major global health threat. A new report by The Economist Intelligence Unit makes a compelling argument for ending this scourge. A new Lancet TB Commission provides a roadmap for ending TB.
